- Home
- QNRX vs KXIN Comparison
QNRX vs KXIN Comparison
Compare QNRX & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- KXIN
- Stock Information
- Founded
- QNRX 2018
- KXIN 2015
- Country
- QNRX United States
- KXIN China
- Employees
- QNRX N/A
- KXIN N/A
- Industry
- QNRX Medical/Dental Instruments
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- QNRX Health Care
- KXIN Consumer Discretionary
- Exchange
- QNRX Nasdaq
- KXIN Nasdaq
- Market Cap
- QNRX 3.3M
- KXIN 13.0M
- IPO Year
- QNRX N/A
- KXIN N/A
- Fundamental
- Price
- QNRX $6.26
- KXIN $0.89
- Analyst Decision
- QNRX
- KXIN
- Analyst Count
- QNRX 0
- KXIN 0
- Target Price
- QNRX N/A
- KXIN N/A
- AVG Volume (30 Days)
- QNRX 44.8K
- KXIN 63.0K
- Earning Date
- QNRX 05-13-2025
- KXIN 11-26-2019
- Dividend Yield
- QNRX N/A
- KXIN N/A
- EPS Growth
- QNRX N/A
- KXIN N/A
- EPS
- QNRX N/A
- KXIN N/A
- Revenue
- QNRX N/A
- KXIN N/A
- Revenue This Year
- QNRX N/A
- KXIN N/A
- Revenue Next Year
- QNRX N/A
- KXIN N/A
- P/E Ratio
- QNRX N/A
- KXIN N/A
- Revenue Growth
- QNRX N/A
- KXIN N/A
- 52 Week Low
- QNRX $5.01
- KXIN $0.64
- 52 Week High
- QNRX $54.95
- KXIN $29.52
- Technical
- Relative Strength Index (RSI)
- QNRX 42.24
- KXIN 43.91
- Support Level
- QNRX $6.05
- KXIN $0.85
- Resistance Level
- QNRX $7.09
- KXIN $0.94
- Average True Range (ATR)
- QNRX 0.74
- KXIN 0.07
- MACD
- QNRX 0.15
- KXIN -0.01
- Stochastic Oscillator
- QNRX 41.50
- KXIN 12.91
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.